Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Dopamina antagonista")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 224

  • Page / 9
Export

Selection :

  • and

SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphineMEREU, G; COLLU, M; ONGINI, E et al.European journal of pharmacology. 1985, Vol 111, Num 3, pp 393-396, issn 0014-2999Article

Effect of haloperidol on dopamine-induced increase in renal blood flowARMSTRONG, D. K; DASTA, J. F; REILLEY, T. E et al.Drug intelligence & clinical pharmacy. 1986, Vol 20, Num 7-8, pp 543-546, issn 0012-6578Article

[3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptorsPORCEDDU, M. L; ONGINI, E; BIGGIO, G et al.European journal of pharmacology. 1985, Vol 118, Num 3, pp 367-370, issn 0014-2999Article

BRL 20596, a novel anilide with central dopamine antagonist activityCAMPBELL, W; CLARK, M. S. G; MITCHELL, P. J et al.Psychopharmacologia. 1986, Vol 89, Num 2, pp 208-215, issn 0033-3158Article

Bilateral ballistic movements occuring as a late complication of hemispherectomy and responding to sulpirideWROE, S; RICHENS, A; COMPSTON, A et al.Journal of neurology. 1986, Vol 233, Num 5, pp 315-316, issn 0340-5354Article

Antipsychotic effect of remoxipride, a new substituted benzamide with selective antidopaminergic activityLAURSEN, A. L; GERLACH, J.Acta psychiatrica Scandinavica. 1986, Vol 73, Num 1, pp 17-21, issn 0001-690XArticle

Remoxipride in the treatment of acute maniaCHOUINARD, G; STEINER, W.Biological psychiatry (1969). 1986, Vol 21, Num 14, pp 1429-1433, issn 0006-3223Article

D-1 dopamine receptor stimulation elevates plasma prolactin levelsSALLER, C. F; SALAMA, A. I.European journal of pharmacology. 1986, Vol 122, Num 1, pp 139-142, issn 0014-2999Article

Domperidone and Parkinson's diseasePARKES, J. D.Clinical neuropharmacology. 1986, Vol 9, Num 6, pp 517-532, issn 0362-5664Article

Efficacité et tolérance du veralipride dans le traitement des bouffées de chaleur de la ménopause: Etude multicentrique = Efficacy and tolerance of veralipride in the treatment of sudden flushes of menopause. A multicentric studyBOUKOBZA, G.Revue française de gynécologie et d'obstétrique. 1986, Vol 81, Num 8, pp 413-417, issn 0035-290XArticle

Dopamine antagonists reduce spontaneous electrical activity in cultured mammalian neurons from ventral mesencephalonHEYER, E. J.Brain research. 1986, Vol 382, Num 2, pp 404-408, issn 0006-8993Article

Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3-benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detectionKILTS, C. D; DEW, K. L; ELY, T. D et al.Journal of chromatography. 1985, Vol 342, Num 2, pp 452-457, issn 0021-9673Article

6-(-2-amino-ethyl) benzoxazolinones: potent dopaminergic antagonistsBRUNET, C; LUYCKX, M; CAZIN, M et al.Acta therapeutica. 1987, Vol 13, Num 2, pp 125-139, issn 0378-0619Article

Inhibition of human neuroblastoma by dopamine antagonistsMCGRATH, P. C; NEIFELD, J. P.Surgery. 1985, Vol 98, Num 2, pp 135-142, issn 0039-6060Article

Modulatory role for prolactin in the elevation of striatal dopamine receptor density induced by chronic treatment with dopamine receptor antagonistsHRUSKA, R. E.Brain research bulletin. 1986, Vol 16, Num 3, pp 331-339, issn 0361-9230Article

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in miceHEIKKILA, R. E; MANZINO, L; CABBAT, F. S et al.Neuroscience letters. 1985, Vol 58, Num 1, pp 133-137, issn 0304-3940Article

High-performance liquid chromatographic determination of a new benzamide in biological fluids for use in a human pharmacokinetic studyBRESSOLLE, F; BRES, J; SNOUSSI, M et al.Journal of chromatography. 1985, Vol 343, Num 2, pp 443-448, issn 0021-9673Article

Postoperative neurologic dysfunction associated with preoperative administration of metoclopramideSCHELLER, M. S; SEARS, K. L.Anesthesia and analgesia. 1987, Vol 66, Num 3, pp 274-276, issn 0003-2999Article

Analgesic effect of metoclopramide and its mechanismRAMASWAMY, S; BAPNA, J. S.Life sciences (1973). 1986, Vol 38, Num 14, pp 1289-1292, issn 0024-3205Article

Different effects of metoclopramide and domperidone on arginine-vasopressin secretion in manCHIODERA, P; VOLPI, R; DELSIGNORE, R et al.British journal of clinical pharmacology. 1986, Vol 22, Num 4, pp 479-482, issn 0306-5251Article

A novel long-lasting dopamine receptor blocker: haloperidol-bovine serum albumin conjugateGARRIGUES, A.-M; STINUS, L; TAGHZOUTI, K et al.European journal of pharmacology. 1985, Vol 118, Num 3, pp 313-319, issn 0014-2999Article

Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brainARNT, J; CHRISTENSEN, A. V; HYTTEL, J et al.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 329, Num 2, pp 101-107, issn 0028-1298Article

Potential uses for metoclopramideSHAUGHNESSY, A. F.Drug intelligence & clinical pharmacy. 1985, Vol 19, Num 10, pp 723-728, issn 0012-6578Article

The clinical significance of halopemide, a dopamine-blocker related to the butyrophenonesDE CUYPER, H; VAN PRAAG, H. M; VERSTRAETEN, D et al.Neuropsychobiology. 1984, Vol 12, Num 4, pp 211-216, issn 0302-282XArticle

Effects of dopaminergic agonists and antagonists on the partially contracted, isolated and perfused renal artery of the ratRODRIGUEZ-MENDEZ, S. A; FERIA, M; BOADA, J et al.Pharmacology. 1986, Vol 32, Num 6, pp 321-325, issn 0031-7012Article

  • Page / 9